Our study has identified the GJB4 rs200602523 variant (c.292C>T: p. R98C) as a pathogenic mutation associated with PFO and cardiomyopathy, highlighting its systemic impact on cardiovascular health. This evidence concerns the gene GJB4 and cardiomyopathy.